Benefits for Women With Women-Only Cardiac Rehab

This article originally appeared here.
Share this content:
Benefits for Women With Women-Only Cardiac Rehab
Benefits for Women With Women-Only Cardiac Rehab

WEDNESDAY, Feb. 3, 2016 (HealthDay News) -- Women-only cardiac rehabilitation (CR) programs may confer behavioral and psychosocial advantages for women, according to a study published online Feb. 2 in the Canadian Journal of Cardiology.

Liz Midence, from York University in Toronto, and colleagues examined whether participation in women-only CR results in better outcomes than other models. Low-risk cardiac patients were recruited and surveyed regarding their health behaviors and psychosocial well-being. One hundred sixty-nine eligible participants were randomly allocated to mixed-sex, women-only, or home-based CR; 116 patients were retained.

The researchers found that women in mixed-sex and women-only CR groups had increased self-reported physical activity (per protocol and as treated, P < 0.05), and improvement in quality of life (per protocol and as treated, P < 0.05). Women in the women-only CR group had improvement in diet (as treated, P < 0.05). Compared with women in the women-only CR group, women in the mixed-sex CR group had higher anxiety symptoms (per protocol, P = 0.017) and higher depressive symptoms (as treated, P = 0.001). After adjustment for confounding variables there were no significant differences in any outcome by model.

"Behavioral and psychosocial outcomes were largely equivalent regardless of model; however, women-only programs may confer an advantage for anxiety and depressive symptoms," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »